Insider · CIK 0001430466
Waleed H Hassanein
Files at TMDX (TransMedics Group, Inc.). First filing Nov 9, 2023, latest Nov 18, 2025.
In brief
Waleed H Hassanein files SEC Form 4 as CEO, president and director at TMDX (TransMedics Group, Inc.). Since Nov 9, 2023, Waleed H Hassanein has reported 2 open-market buys worth $3.0M and 3 open-market sells worth $2.7M, the latest filed on Nov 18, 2025.
A track record needs three past buys with six months of prices behind them; Waleed H Hassanein has 2, so none is measured yet.
The newest scored trade: bought $1.0M of TMDX on Nov 17, 2025, filed Nov 18, 2025, scored 54 (moderate). In the last 12 months: 1 buy worth $1.0M and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TMDX: TransMedics Group, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 54Moderate | TMDXbuy TransMedics Group, Inc. | $1.0M 8,775 shares | +2% | +100% from low-21% from high | |
| 54Moderate | TMDXbuy TransMedics Group, Inc. | $2.0M 16,875 shares | +4% | +109% from low-28% from high | |
| 20Weak | TransMedics Group, Inc. | $1.1M 8,625 shares | -12% | - | |
| 32Weak | TransMedics Group, Inc. | $558k 7,500 shares | -1% | +103% from low-22% from high | |
| 30Weak | TransMedics Group, Inc. | $965k 15,000 shares | -3% | +65% from low-37% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Nov 7, 2023 | TMDX Transmedics Group Inc | 22,500 0.07% of outstanding | $1.4M | Nov 7, 2023 | $512k |
Transactions
Every row this insider has filed, 18 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 10, 2026 | TMDX TransMedics Group, Inc. | AGrant or award Common Stock | +49,669 | $0.00 | $0 | 171,093 | Jul 14, 2026 |
| Jul 10, 2026 | TMDX TransMedics Group, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +112,984 | $0.00 | $0 | 112,984 | Jul 14, 2026 |
| Nov 17, 2025 | TMDX TransMedics Group, Inc. | POpen-market purchase Common Stockindirect: By the Waleed H. Hassanein Revocable Trust | +8,775 | $114.00 | $1.0M | 495,009 | Nov 18, 2025 |
| Aug 6, 2025 | TMDX TransMedics Group, Inc. | POpen-market purchase Common Stockindirect: By the Waleed H. Hassanein Revocable Trust | +8,400 | $118.68 | $997k | 477,759 | Aug 8, 2025 |
| Aug 7, 2025 | TMDX TransMedics Group, Inc. | POpen-market purchase Common Stockindirect: By the Waleed H. Hassanein Revocable Trust | +6,617 | $116.08 | $768k | 484,376 | Aug 8, 2025 |
| Aug 7, 2025 | TMDX TransMedics Group, Inc. | POpen-market purchase Common Stockindirect: By the Waleed H. Hassanein Revocable Trust | +1,858 | $116.85 | $217k | 486,234 | Aug 8, 2025 |
| Feb 25, 2025 | TMDX TransMedics Group, Inc. | AGrant or award Common Stock | +59,781 | $0.00 | $0 | 121,424 | Feb 26, 2025 |
| Feb 25, 2025 | TMDX TransMedics Group, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +90,185 | $0.00 | $0 | 90,185 | Feb 26, 2025 |
| Oct 15, 2024 | TMDX TransMedics Group, Inc. | MOption exercise Common Stock10b5-1 | +8,625 | $13.28 | $115k | 70,268 | Oct 17, 2024 |
| Oct 15, 2024 | TMDX TransMedics Group, Inc. | SOpen-market sale Common Stock10b5-1 | -3,607 | $131.91 | $476k | 66,661 | Oct 17, 2024 |
| Oct 15, 2024 | TMDX TransMedics Group, Inc. | SOpen-market sale Common Stock10b5-1 | -3,518 | $132.82 | $467k | 63,143 | Oct 17, 2024 |
| Oct 15, 2024 | TMDX TransMedics Group, Inc. | SOpen-market sale Common Stock10b5-1 | -1,200 | $134.23 | $161k | 61,943 | Oct 17, 2024 |
| Oct 15, 2024 | TMDX TransMedics Group, Inc. | SOpen-market sale Common Stock10b5-1 | -300 | $135.04 | $41k | 61,643 | Oct 17, 2024 |
| Oct 15, 2024 | TMDX TransMedics Group, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -8,625 | $0.00 | $0 | 96,250 | Oct 17, 2024 |
| Dec 1, 2023 | TMDX TransMedics Group, Inc. | SOpen-market sale Common Stock10b5-1 | -2,925 | $74.06 | $217k | 511,266 | Dec 5, 2023 |
| Dec 1, 2023 | TMDX TransMedics Group, Inc. | SOpen-market sale Common Stock10b5-1 | -4,475 | $74.61 | $334k | 506,791 | Dec 5, 2023 |
| Dec 1, 2023 | TMDX TransMedics Group, Inc. | SOpen-market sale Common Stock10b5-1 | -100 | $75.28 | $7,528 | 506,691 | Dec 5, 2023 |
| Nov 7, 2023 | TMDX TransMedics Group, Inc. | SOpen-market sale Common Stock10b5-1 | -15,000 | $64.32 | $965k | 514,191 | Nov 9, 2023 |
Questions about Waleed H Hassanein
Answered from the filings on this page, as of the latest one.
Is Waleed H Hassanein buying or selling?
In the last 12 months Waleed H Hassanein reported 1 open-market buy worth $1.0M and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $1.0M of TMDX on Nov 17, 2025. Grants, option exercises and tax withholding are not counted.
How did Waleed H Hassanein's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Waleed H Hassanein has 2.
Where does Waleed H Hassanein file Form 4?
Waleed H Hassanein has filed Form 4 at TMDX (TransMedics Group, Inc.) as President & CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.